 Patrick Reid
Concepts (268)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholesterol | 8 | 2007 | 408 | 0.930 |
Why?
| | Spinal Neoplasms | 1 | 2025 | 37 | 0.900 |
Why?
| | Peptides, Cyclic | 4 | 2024 | 273 | 0.820 |
Why?
| | Spinal Fusion | 4 | 2025 | 262 | 0.780 |
Why?
| | Time-to-Treatment | 1 | 2025 | 251 | 0.760 |
Why?
| | Lumbar Vertebrae | 2 | 2025 | 252 | 0.700 |
Why?
| | Intervertebral Disc Degeneration | 1 | 2019 | 33 | 0.580 |
Why?
| | Decompressive Craniectomy | 1 | 2018 | 9 | 0.560 |
Why?
| | Trauma, Nervous System | 1 | 2017 | 3 | 0.540 |
Why?
| | Hypoglossal Nerve Diseases | 1 | 2017 | 3 | 0.530 |
Why?
| | Surgical Flaps | 1 | 2018 | 142 | 0.500 |
Why?
| | Brain Injuries, Traumatic | 2 | 2025 | 453 | 0.500 |
Why?
| | Sulfides | 2 | 2021 | 92 | 0.490 |
Why?
| | Niemann-Pick Diseases | 6 | 2005 | 8 | 0.390 |
Why?
| | Proprotein Convertase 9 | 2 | 2024 | 87 | 0.380 |
Why?
| | Membrane Microdomains | 3 | 2007 | 34 | 0.330 |
Why?
| | Sterols | 2 | 2007 | 20 | 0.330 |
Why?
| | RNA, Catalytic | 1 | 2012 | 191 | 0.330 |
Why?
| | RNA, Transfer | 1 | 2012 | 143 | 0.320 |
Why?
| | Peptides | 5 | 2024 | 998 | 0.310 |
Why?
| | Escherichia coli | 2 | 2024 | 835 | 0.280 |
Why?
| | Spinal Diseases | 2 | 2019 | 50 | 0.280 |
Why?
| | Farnesyl-Diphosphate Farnesyltransferase | 1 | 2007 | 1 | 0.270 |
Why?
| | Terpenes | 1 | 2007 | 24 | 0.250 |
Why?
| | Neurons | 3 | 2007 | 1649 | 0.250 |
Why?
| | Receptors, LDL | 2 | 2024 | 53 | 0.230 |
Why?
| | Hepatocytes | 2 | 2025 | 224 | 0.220 |
Why?
| | Anticholesteremic Agents | 1 | 2007 | 155 | 0.220 |
Why?
| | Receptors, Somatotropin | 1 | 2025 | 10 | 0.220 |
Why?
| | Zygapophyseal Joint | 1 | 2025 | 8 | 0.220 |
Why?
| | Acromegaly | 1 | 2025 | 17 | 0.220 |
Why?
| | Octreotide | 1 | 2025 | 23 | 0.220 |
Why?
| | Enzyme Inhibitors | 2 | 2007 | 820 | 0.210 |
Why?
| | Decompression, Surgical | 1 | 2025 | 116 | 0.210 |
Why?
| | Bacterial Outer Membrane Proteins | 1 | 2024 | 62 | 0.210 |
Why?
| | Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2023 | 2 | 0.210 |
Why?
| | Cysts | 1 | 2025 | 112 | 0.210 |
Why?
| | Peptide Library | 3 | 2013 | 91 | 0.200 |
Why?
| | Proteins | 2 | 2007 | 1023 | 0.200 |
Why?
| | Intracellular Signaling Peptides and Proteins | 7 | 2009 | 456 | 0.190 |
Why?
| | Staining and Labeling | 1 | 2004 | 153 | 0.190 |
Why?
| | Macrophages, Peritoneal | 1 | 2003 | 89 | 0.190 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2025 | 317 | 0.190 |
Why?
| | Escherichia coli Proteins | 1 | 2024 | 201 | 0.180 |
Why?
| | Syringomyelia | 1 | 2022 | 12 | 0.180 |
Why?
| | Arachnoid Cysts | 1 | 2022 | 10 | 0.180 |
Why?
| | Spinal Cord Diseases | 1 | 2022 | 42 | 0.180 |
Why?
| | Neuroglia | 1 | 2003 | 173 | 0.170 |
Why?
| | Fibroblasts | 3 | 2005 | 1025 | 0.170 |
Why?
| | Transferases | 1 | 2021 | 27 | 0.170 |
Why?
| | Brain | 3 | 2018 | 2947 | 0.170 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2025 | 499 | 0.170 |
Why?
| | Alzheimer Disease | 1 | 2007 | 630 | 0.160 |
Why?
| | Lipoproteins | 1 | 2021 | 166 | 0.160 |
Why?
| | Humans | 32 | 2025 | 145474 | 0.150 |
Why?
| | Anticoagulants | 1 | 2025 | 748 | 0.150 |
Why?
| | Evoked Potentials, Motor | 1 | 2019 | 52 | 0.150 |
Why?
| | Intraoperative Neurophysiological Monitoring | 1 | 2019 | 32 | 0.140 |
Why?
| | Pedicle Screws | 1 | 2018 | 23 | 0.130 |
Why?
| | Osteotomy | 1 | 2019 | 128 | 0.130 |
Why?
| | Intracranial Hypertension | 1 | 2018 | 42 | 0.130 |
Why?
| | Cranial Nerves | 1 | 2017 | 12 | 0.130 |
Why?
| | Bone Transplantation | 1 | 2018 | 88 | 0.130 |
Why?
| | Retrospective Studies | 5 | 2025 | 17291 | 0.130 |
Why?
| | Middle Aged | 7 | 2025 | 36215 | 0.130 |
Why?
| | Medulla Oblongata | 1 | 2017 | 37 | 0.130 |
Why?
| | Scoliosis | 1 | 2020 | 221 | 0.130 |
Why?
| | Glasgow Coma Scale | 1 | 2018 | 218 | 0.130 |
Why?
| | Cervical Vertebrae | 1 | 2018 | 168 | 0.120 |
Why?
| | Membrane Glycoproteins | 5 | 2005 | 499 | 0.120 |
Why?
| | Carrier Proteins | 5 | 2006 | 728 | 0.120 |
Why?
| | Aged, 80 and over | 3 | 2025 | 8333 | 0.110 |
Why?
| | Animals | 17 | 2025 | 38030 | 0.110 |
Why?
| | Protein Conformation | 3 | 2024 | 938 | 0.110 |
Why?
| | Transcription Factors | 1 | 2023 | 1734 | 0.110 |
Why?
| | Cohort Studies | 1 | 2025 | 6013 | 0.110 |
Why?
| | Female | 12 | 2025 | 78844 | 0.100 |
Why?
| | Mice, Inbred BALB C | 3 | 2007 | 1261 | 0.100 |
Why?
| | CHO Cells | 5 | 2007 | 169 | 0.100 |
Why?
| | Aged | 4 | 2025 | 26153 | 0.100 |
Why?
| | Cricetinae | 5 | 2007 | 305 | 0.100 |
Why?
| | Mice | 11 | 2021 | 18329 | 0.100 |
Why?
| | Imaging, Three-Dimensional | 1 | 2017 | 583 | 0.100 |
Why?
| | Aspartic Acid Endopeptidases | 2 | 2021 | 32 | 0.100 |
Why?
| | Puromycin | 1 | 2013 | 10 | 0.100 |
Why?
| | Macrocyclic Compounds | 1 | 2013 | 15 | 0.100 |
Why?
| | Male | 10 | 2025 | 72842 | 0.100 |
Why?
| | Glioma | 1 | 2018 | 429 | 0.100 |
Why?
| | Biological Transport | 5 | 2007 | 424 | 0.100 |
Why?
| | Animals, Newborn | 2 | 2007 | 891 | 0.100 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2013 | 86 | 0.090 |
Why?
| | Multiple Sclerosis | 1 | 2018 | 489 | 0.090 |
Why?
| | Protein Binding | 4 | 2024 | 2238 | 0.090 |
Why?
| | Treatment Outcome | 3 | 2025 | 11772 | 0.090 |
Why?
| | Molecular Structure | 2 | 2024 | 486 | 0.090 |
Why?
| | Binding Sites | 2 | 2024 | 1310 | 0.080 |
Why?
| | Cholesterol, LDL | 2 | 2003 | 360 | 0.080 |
Why?
| | Tomography, X-Ray Computed | 2 | 2018 | 2769 | 0.080 |
Why?
| | Ribosomes | 1 | 2012 | 193 | 0.080 |
Why?
| | Clinical Competence | 1 | 2018 | 1243 | 0.080 |
Why?
| | Time Factors | 3 | 2007 | 7123 | 0.080 |
Why?
| | Spine | 2 | 2022 | 182 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 2 | 2022 | 3904 | 0.070 |
Why?
| | Cyclodextrins | 3 | 2003 | 11 | 0.070 |
Why?
| | Drug Discovery | 2 | 2024 | 153 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2024 | 2028 | 0.070 |
Why?
| | Polymerase Chain Reaction | 1 | 2012 | 1041 | 0.070 |
Why?
| | Structure-Activity Relationship | 2 | 2024 | 563 | 0.070 |
Why?
| | Brain Neoplasms | 1 | 2018 | 1329 | 0.070 |
Why?
| | Adult | 7 | 2023 | 40777 | 0.070 |
Why?
| | Adenoviridae | 2 | 2006 | 199 | 0.070 |
Why?
| | Tritium | 1 | 2007 | 67 | 0.070 |
Why?
| | Gangliosides | 1 | 2007 | 23 | 0.070 |
Why?
| | Lovastatin | 1 | 2007 | 37 | 0.070 |
Why?
| | Muscle Proteins | 1 | 2009 | 242 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 2 | 2025 | 2524 | 0.060 |
Why?
| | Apolipoprotein A-I | 2 | 2004 | 39 | 0.060 |
Why?
| | Young Adult | 3 | 2019 | 14218 | 0.060 |
Why?
| | Acetates | 1 | 2007 | 78 | 0.060 |
Why?
| | Neoplasms | 1 | 2023 | 2906 | 0.060 |
Why?
| | Serum Amyloid P-Component | 1 | 2006 | 3 | 0.060 |
Why?
| | Cyclin A | 1 | 2006 | 17 | 0.060 |
Why?
| | Lipoproteins, HDL | 2 | 2004 | 100 | 0.060 |
Why?
| | G2 Phase | 1 | 2006 | 39 | 0.060 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2006 | 42 | 0.060 |
Why?
| | Green Fluorescent Proteins | 2 | 2005 | 407 | 0.060 |
Why?
| | Angina, Unstable | 1 | 2006 | 83 | 0.060 |
Why?
| | Rats | 3 | 2025 | 5584 | 0.060 |
Why?
| | Mice, Mutant Strains | 2 | 2003 | 302 | 0.060 |
Why?
| | In Vitro Techniques | 1 | 2007 | 1048 | 0.060 |
Why?
| | Endosomes | 2 | 2005 | 140 | 0.060 |
Why?
| | Genetic Techniques | 1 | 2005 | 66 | 0.060 |
Why?
| | Adolescent | 3 | 2020 | 22529 | 0.050 |
Why?
| | Cell Division | 1 | 2006 | 756 | 0.050 |
Why?
| | Endoplasmic Reticulum | 2 | 2007 | 264 | 0.050 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2006 | 218 | 0.050 |
Why?
| | Models, Molecular | 2 | 2024 | 1598 | 0.050 |
Why?
| | Intracranial Hemorrhages | 1 | 2025 | 106 | 0.050 |
Why?
| | Amyloid beta-Peptides | 1 | 2007 | 244 | 0.050 |
Why?
| | Lipid Metabolism | 2 | 2005 | 529 | 0.050 |
Why?
| | C-Reactive Protein | 1 | 2006 | 422 | 0.050 |
Why?
| | Fatty Acids | 1 | 2007 | 457 | 0.050 |
Why?
| | Mice, Neurologic Mutants | 1 | 2004 | 21 | 0.050 |
Why?
| | Drug Synergism | 1 | 2025 | 354 | 0.050 |
Why?
| | Cell Membrane | 1 | 2007 | 707 | 0.050 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2004 | 117 | 0.050 |
Why?
| | Monocytes | 1 | 2006 | 539 | 0.050 |
Why?
| | Brain Chemistry | 1 | 2004 | 119 | 0.050 |
Why?
| | Protein Conformation, alpha-Helical | 1 | 2023 | 18 | 0.050 |
Why?
| | Molecular Probes | 1 | 2003 | 33 | 0.050 |
Why?
| | beta-Cyclodextrins | 1 | 2003 | 32 | 0.050 |
Why?
| | Mutation | 5 | 2007 | 4075 | 0.050 |
Why?
| | Bacterial Toxins | 1 | 2003 | 108 | 0.050 |
Why?
| | Laminectomy | 1 | 2022 | 31 | 0.050 |
Why?
| | Anti-Bacterial Agents | 2 | 2024 | 1923 | 0.040 |
Why?
| | Reoperation | 1 | 2025 | 633 | 0.040 |
Why?
| | Back Pain | 1 | 2022 | 52 | 0.040 |
Why?
| | Uropathogenic Escherichia coli | 1 | 2021 | 4 | 0.040 |
Why?
| | Hep G2 Cells | 1 | 2021 | 73 | 0.040 |
Why?
| | Nuclear Proteins | 1 | 2006 | 740 | 0.040 |
Why?
| | Peptidoglycan | 1 | 2021 | 28 | 0.040 |
Why?
| | Madin Darby Canine Kidney Cells | 1 | 2021 | 17 | 0.040 |
Why?
| | Caco-2 Cells | 1 | 2021 | 79 | 0.040 |
Why?
| | Cell Membrane Permeability | 1 | 2021 | 88 | 0.040 |
Why?
| | Methylation | 1 | 2021 | 242 | 0.040 |
Why?
| | Mice, Knockout | 1 | 2007 | 3124 | 0.040 |
Why?
| | Endothelium, Vascular | 1 | 2006 | 956 | 0.040 |
Why?
| | Small Molecule Libraries | 1 | 2021 | 111 | 0.040 |
Why?
| | Gene Deletion | 1 | 2021 | 391 | 0.040 |
Why?
| | Dogs | 1 | 2021 | 458 | 0.040 |
Why?
| | Observer Variation | 1 | 2020 | 357 | 0.040 |
Why?
| | Ligands | 1 | 2021 | 665 | 0.040 |
Why?
| | Evoked Potentials, Somatosensory | 1 | 2019 | 39 | 0.040 |
Why?
| | DNA-Binding Proteins | 1 | 2006 | 1480 | 0.040 |
Why?
| | Cell Line, Tumor | 2 | 2023 | 3542 | 0.040 |
Why?
| | Lumbosacral Region | 1 | 2019 | 59 | 0.040 |
Why?
| | Microscopy, Fluorescence | 3 | 2005 | 408 | 0.040 |
Why?
| | Thermodynamics | 1 | 2021 | 419 | 0.040 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2021 | 337 | 0.040 |
Why?
| | Liver | 1 | 2007 | 1896 | 0.040 |
Why?
| | Administration, Oral | 1 | 2021 | 866 | 0.030 |
Why?
| | Radiography | 1 | 2020 | 852 | 0.030 |
Why?
| | Inflammation | 1 | 2009 | 2878 | 0.030 |
Why?
| | Neurosurgical Procedures | 1 | 2019 | 202 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2021 | 5983 | 0.030 |
Why?
| | Bacterial Proteins | 1 | 2021 | 967 | 0.030 |
Why?
| | Gene Expression Regulation | 3 | 2009 | 2597 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2018 | 1508 | 0.020 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2013 | 104 | 0.020 |
Why?
| | Serum Albumin | 1 | 2013 | 147 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2020 | 3413 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 2 | 2005 | 666 | 0.020 |
Why?
| | Cells, Cultured | 2 | 2009 | 4148 | 0.020 |
Why?
| | Pregnancy | 1 | 2003 | 7202 | 0.020 |
Why?
| | GATA2 Transcription Factor | 1 | 2009 | 14 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2013 | 2129 | 0.020 |
Why?
| | NFATC Transcription Factors | 1 | 2009 | 94 | 0.020 |
Why?
| | RNA, Messenger | 2 | 2006 | 2803 | 0.020 |
Why?
| | Models, Biological | 2 | 2007 | 1764 | 0.020 |
Why?
| | Cell Line | 2 | 2004 | 2823 | 0.020 |
Why?
| | Calcium-Binding Proteins | 1 | 2009 | 221 | 0.020 |
Why?
| | Chromatography, Thin Layer | 1 | 2007 | 24 | 0.020 |
Why?
| | Subcellular Fractions | 1 | 2007 | 73 | 0.020 |
Why?
| | Cricetulus | 1 | 2007 | 118 | 0.020 |
Why?
| | Leupeptins | 1 | 2006 | 13 | 0.020 |
Why?
| | Chromones | 1 | 2006 | 43 | 0.020 |
Why?
| | E-Selectin | 1 | 2006 | 61 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2009 | 552 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2019 | 2970 | 0.010 |
Why?
| | DNA | 1 | 2013 | 1435 | 0.010 |
Why?
| | Hydroxamic Acids | 1 | 2006 | 94 | 0.010 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2006 | 132 | 0.010 |
Why?
| | RNA Splicing Factors | 1 | 2006 | 66 | 0.010 |
Why?
| | Models, Chemical | 1 | 2007 | 250 | 0.010 |
Why?
| | 3' Untranslated Regions | 1 | 2006 | 149 | 0.010 |
Why?
| | Azepines | 1 | 2006 | 105 | 0.010 |
Why?
| | Embryo, Mammalian | 1 | 2006 | 234 | 0.010 |
Why?
| | Morpholines | 1 | 2006 | 130 | 0.010 |
Why?
| | Lipopolysaccharides | 1 | 2009 | 858 | 0.010 |
Why?
| | Detergents | 1 | 2005 | 43 | 0.010 |
Why?
| | Transduction, Genetic | 1 | 2005 | 132 | 0.010 |
Why?
| | Cell Adhesion | 1 | 2006 | 451 | 0.010 |
Why?
| | Histone Deacetylases | 1 | 2006 | 207 | 0.010 |
Why?
| | Endopeptidases | 1 | 2005 | 80 | 0.010 |
Why?
| | Immunoprecipitation | 1 | 2005 | 148 | 0.010 |
Why?
| | ATP Binding Cassette Transporter 1 | 1 | 2004 | 13 | 0.010 |
Why?
| | Sterol O-Acyltransferase | 1 | 2004 | 6 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2009 | 1246 | 0.010 |
Why?
| | Apolipoproteins | 1 | 2004 | 38 | 0.010 |
Why?
| | Lysosomes | 1 | 2005 | 131 | 0.010 |
Why?
| | Transcriptional Activation | 1 | 2006 | 372 | 0.010 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2005 | 78 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 848 | 0.010 |
Why?
| | Vesicular Transport Proteins | 1 | 2005 | 85 | 0.010 |
Why?
| | RNA, Small Interfering | 1 | 2006 | 637 | 0.010 |
Why?
| | Ovary | 1 | 2005 | 233 | 0.010 |
Why?
| | Astrocytes | 1 | 2005 | 228 | 0.010 |
Why?
| | Biological Transport, Active | 1 | 2003 | 69 | 0.010 |
Why?
| | Filipin | 1 | 2003 | 4 | 0.010 |
Why?
| | Cell Compartmentation | 1 | 2003 | 52 | 0.010 |
Why?
| | Transfection | 1 | 2005 | 926 | 0.010 |
Why?
| | Protein Kinase C | 1 | 2004 | 251 | 0.010 |
Why?
| | Glycoproteins | 1 | 2005 | 354 | 0.010 |
Why?
| | Biotinylation | 1 | 2003 | 37 | 0.010 |
Why?
| | Pancreatic Elastase | 1 | 2003 | 53 | 0.010 |
Why?
| | Endothelial Cells | 1 | 2009 | 874 | 0.010 |
Why?
| | Hemolysin Proteins | 1 | 2003 | 36 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2004 | 762 | 0.010 |
Why?
| | Lipase | 1 | 2003 | 75 | 0.010 |
Why?
| | Membrane Lipids | 1 | 2003 | 82 | 0.010 |
Why?
| | Cell Cycle Proteins | 1 | 2006 | 630 | 0.010 |
Why?
| | Lipids | 1 | 2007 | 707 | 0.010 |
Why?
| | Blotting, Western | 1 | 2005 | 1179 | 0.010 |
Why?
| | Luminescent Proteins | 1 | 2003 | 186 | 0.010 |
Why?
| | Age Factors | 1 | 2009 | 3342 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2006 | 1997 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2006 | 1217 | 0.010 |
Why?
| | Genotype | 1 | 2006 | 1852 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2006 | 2188 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2006 | 2121 | 0.010 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2005 | 443 | 0.010 |
Why?
| | Coronary Artery Disease | 1 | 2006 | 749 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2003 | 1162 | 0.010 |
Why?
| | Phenotype | 1 | 2005 | 3155 | 0.010 |
Why?
| | Biomarkers | 1 | 2006 | 4295 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2005 | 4560 | 0.010 |
Why?
| | Signal Transduction | 1 | 2006 | 5216 | 0.010 |
Why?
| | Risk Factors | 1 | 2006 | 10885 | 0.010 |
Why?
|
|
Reid's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|